241 related articles for article (PubMed ID: 33232271)
41. Co-delivery of docetaxel and gemcitabine using PEGylated self-assembled stealth nanoparticles for improved breast cancer therapy.
Kushwah V; Katiyar SS; Agrawal AK; Gupta RC; Jain S
Nanomedicine; 2018 Jul; 14(5):1629-1641. PubMed ID: 29684527
[TBL] [Abstract][Full Text] [Related]
42. Zinc oxide nanoparticles induce human multiple myeloma cell death via reactive oxygen species and Cyt-C/Apaf-1/Caspase-9/Caspase-3 signaling pathway in vitro.
Li Z; Guo D; Yin X; Ding S; Shen M; Zhang R; Wang Y; Xu R
Biomed Pharmacother; 2020 Feb; 122():109712. PubMed ID: 31918281
[TBL] [Abstract][Full Text] [Related]
43. Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species.
Akhtar MJ; Ahamed M; Kumar S; Khan MM; Ahmad J; Alrokayan SA
Int J Nanomedicine; 2012; 7():845-57. PubMed ID: 22393286
[TBL] [Abstract][Full Text] [Related]
44. Promotion of tumor progression induced by continuous low-dose administration of antineoplastic agent gemcitabine or gemcitabine combined with cisplatin.
Chen Y; Liu H; Zheng Q; Li H; You H; Feng Y; Feng W
Life Sci; 2022 Oct; 306():120826. PubMed ID: 35870618
[TBL] [Abstract][Full Text] [Related]
45. Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial.
Binder D; Schweisfurth H; Grah C; Schäper C; Temmesfeld-Wollbrück B; Siebert G; Suttorp N; Beinert T
Cancer Chemother Pharmacol; 2007 Jun; 60(1):143-50. PubMed ID: 17031643
[TBL] [Abstract][Full Text] [Related]
46. Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics.
Wang F; Wang Y; Ma Q; Cao Y; Yu B
Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1530-1538. PubMed ID: 27894196
[TBL] [Abstract][Full Text] [Related]
47. Zinc oxide nanoparticles induce apoptosis and autophagy in human ovarian cancer cells.
Bai DP; Zhang XF; Zhang GL; Huang YF; Gurunathan S
Int J Nanomedicine; 2017; 12():6521-6535. PubMed ID: 28919752
[TBL] [Abstract][Full Text] [Related]
48. Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer.
Martoni A; Marino A; Sperandi F; Giaquinta S; Di Fabio F; Melotti B; Guaraldi M; Palomba G; Preti P; Petralia A; Artioli F; Picece V; Farris A; Mantovani L
Eur J Cancer; 2005 Jan; 41(1):81-92. PubMed ID: 15617993
[TBL] [Abstract][Full Text] [Related]
49. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
Li S; Li X; Ding J; Han L; Guo X
Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
[No Abstract] [Full Text] [Related]
50. Desertifilum sp. EAZ03 cell extract as a novel natural source for the biosynthesis of zinc oxide nanoparticles and antibacterial, anticancer and antibiofilm characteristics of synthesized zinc oxide nanoparticles.
Ebadi M; Zolfaghari MR; Aghaei SS; Zargar M; Noghabi KA
J Appl Microbiol; 2022 Jan; 132(1):221-236. PubMed ID: 34101961
[TBL] [Abstract][Full Text] [Related]
51. Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib.
Yin N; Yu H; Zhang X; Lv X
Drug Des Devel Ther; 2020; 14():4465-4475. PubMed ID: 33122890
[TBL] [Abstract][Full Text] [Related]
52. Protective role of zinc oxide nanoparticles in kidney injury induced by cisplatin in rats.
Barakat LAA; Barakat N; Zakaria MM; Khirallah SM
Life Sci; 2020 Dec; 262():118503. PubMed ID: 33007311
[TBL] [Abstract][Full Text] [Related]
53. A Nanoparticle Carrier for Co-Delivery of Gemcitabine and Small Interfering RNA in Pancreatic Cancer Therapy.
Li J; Chen Y; Zeng L; Lian G; Chen S; Li Y; Yang K; Huang K
J Biomed Nanotechnol; 2016 Aug; 12(8):1654-66. PubMed ID: 29342344
[TBL] [Abstract][Full Text] [Related]
54. Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: combination therapy for effective cancer treatment.
Yuan YG; Peng QL; Gurunathan S
Int J Nanomedicine; 2017; 12():6487-6502. PubMed ID: 28919750
[TBL] [Abstract][Full Text] [Related]
55. Tumor-targeted polymeric nanostructured lipid carriers with precise ratiometric control over dual-drug loading for combination therapy in non-small-cell lung cancer.
Liang Y; Tian B; Zhang J; Li K; Wang L; Han J; Wu Z
Int J Nanomedicine; 2017; 12():1699-1715. PubMed ID: 28280336
[TBL] [Abstract][Full Text] [Related]
56. Engineering of gemcitabine coated nano-graphene oxide sheets for efficient near-infrared radiation mediated in vivo lung cancer photothermal therapy.
Wei X; Li P; Zhou H; Hu X; Liu D; Wu J; Wang Y
J Photochem Photobiol B; 2021 Mar; 216():112125. PubMed ID: 33601257
[TBL] [Abstract][Full Text] [Related]
57. Zinc Oxide Nanoparticle Synergizes Sorafenib Anticancer Efficacy with Minimizing Its Cytotoxicity.
Nabil A; Elshemy MM; Asem M; Abdel-Motaal M; Gomaa HF; Zahran F; Uto K; Ebara M
Oxid Med Cell Longev; 2020; 2020():1362104. PubMed ID: 32566073
[TBL] [Abstract][Full Text] [Related]
58. Synergistic combination therapy of lung cancer using lipid-layered cisplatin and oridonin co-encapsulated nanoparticles.
Fan X; Wang T; Ji Z; Li Q; Shen H; Wang J
Biomed Pharmacother; 2021 Sep; 141():111830. PubMed ID: 34146851
[TBL] [Abstract][Full Text] [Related]
59. TNNC1 Reduced Gemcitabine Sensitivity of Nonsmall-Cell Lung Cancer by Increasing Autophagy.
Ye X; Xie G; Liu Z; Tang J; Cui M; Wang C; Guo C; Tang J
Med Sci Monit; 2020 Sep; 26():e922703. PubMed ID: 32946432
[TBL] [Abstract][Full Text] [Related]
60. Specific inhibitor of Notch‑3 enhances the sensitivity of NSCLC cells to gemcitabine.
Hu BD; Guo J; Ye YZ; Du T; Cheng CS; Jiang Q; Liu RN; Zhang YB
Oncol Rep; 2018 Jul; 40(1):155-164. PubMed ID: 29781034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
